# Fresenius Kabi USA, LLC - Inspection Records Source: https://www.globalkeysolutions.net/companies/fresenius-kabi-usa-llc/f0c47fa1-3b76-4e6c-82dd-d703086bdfdc > Inspection records and compliance data for Fresenius Kabi USA, LLC in Grand Island, New York. Access full analysis and detailed observations. --- ## Details - Name: Fresenius Kabi USA, LLC - FEI Number: 3001833549 - City: Grand Island - State: New York - Country Name: United States - Address Line 1: 3159 Staley Rd - Zip Code: 14072 - Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE ## Related Documents - [483 - Fresenius Kabi USA, LLC - 2023-10-13](https://www.globalkeysolutions.net/records/483/fresenius-kabi-usa-llc/475fcb6e-dfe5-45dd-991c-a9313ad63c64) — source: FDA, date: October 13, 2023 - [FDA Inspection 1220482 - Fresenius Kabi USA, LLC - 2023-10-13](https://www.globalkeysolutions.net/records/fda_inspections/fresenius-kabi-usa-llc/a88e316f-f4c4-4146-b519-14affbebe818) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 13, 2023 - [483 - Fresenius Kabi USA, LLC - 2023-08-30](https://www.globalkeysolutions.net/records/483/fresenius-kabi-usa-llc/91efc984-74c0-4435-9a5c-15f4efbc26a7) — source: FDA, date: August 30, 2023 - [FDA Inspection 1216357 - Fresenius Kabi USA, LLC - 2023-08-30](https://www.globalkeysolutions.net/records/fda_inspections/fresenius-kabi-usa-llc/6b172d0c-ba88-4cda-9500-e353ae9c96c7) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 30, 2023 - [FDA Inspection 1216357 - Fresenius Kabi USA, LLC - 2023-08-30](https://www.globalkeysolutions.net/records/fda_inspections/fresenius-kabi-usa-llc/7f0cd17c-920d-421e-8b7c-c5256d920e67) — classification: No Action Indicated (NAI), source: FDA, date: August 30, 2023 - [483 - Fresenius Kabi USA, LLC - 2019-08-12](https://www.globalkeysolutions.net/records/483/fresenius-kabi-usa-llc/90344142-2ce1-4a03-96d2-df8dfafa023e) — source: FDA, date: August 12, 2019 - [FDA Inspection 1099323 - Fresenius Kabi USA, LLC - 2019-08-12](https://www.globalkeysolutions.net/records/fda_inspections/fresenius-kabi-usa-llc/df38d6b1-2a83-4f94-b26f-c9cd94982cd7) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 12, 2019 - [483 - Fresenius Kabi USA, LLC - 2018-06-29](https://www.globalkeysolutions.net/records/483/fresenius-kabi-usa-llc/073d0262-f2d1-4776-9be6-655e8bbf723d) — source: FDA, date: June 29, 2018 - [483 - Fresenius Kabi USA, LLC - 2017-03-30](https://www.globalkeysolutions.net/records/483/fresenius-kabi-usa-llc/463f9a6a-44e5-45a6-8b51-d075f7bf4476) — source: FDA, date: March 30, 2017 - [FDA Inspection 1014707 - Fresenius Kabi USA, LLC - 2017-03-30](https://www.globalkeysolutions.net/records/fda_inspections/fresenius-kabi-usa-llc/27fb2ee2-a807-46e7-8155-c4a761f3b2e1) — classification: No Action Indicated (NAI), source: FDA, date: March 30, 2017 - [FDA Inspection 1014707 - Fresenius Kabi USA, LLC - 2017-03-30](https://www.globalkeysolutions.net/records/fda_inspections/fresenius-kabi-usa-llc/fa80ae85-8005-43d6-9e43-13e92aa608d0) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 30, 2017 - [FDA Inspection 1002820 - Fresenius Kabi USA, LLC - 2017-02-01](https://www.globalkeysolutions.net/records/fda_inspections/fresenius-kabi-usa-llc/252f9abd-eb39-4e89-a14e-68bb888a36c1) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 1, 2017 - [483 - Fresenius Kabi USA, LLC - 2016-02-04](https://www.globalkeysolutions.net/records/483/fresenius-kabi-usa-llc/ac69efb9-d106-4581-b88d-dc3e158ca870) — source: FDA, date: February 4, 2016 - [FDA Inspection 962308 - Fresenius Kabi USA, LLC - 2016-02-04](https://www.globalkeysolutions.net/records/fda_inspections/fresenius-kabi-usa-llc/6e9fb937-55f5-4054-923c-bc884ae55733) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 4, 2016 - [483 - Fresenius Kabi USA, LLC - 2015-03-06](https://www.globalkeysolutions.net/records/483/fresenius-kabi-usa-llc/5a97e654-80ca-4e64-89c7-e6f46bad9237) — source: FDA, date: March 6, 2015 - [483 - Fresenius Kabi USA, LLC - 2014-10-24](https://www.globalkeysolutions.net/records/483/fresenius-kabi-usa-llc/748ccfb6-38af-4b50-af00-f7af728729ca) — source: FDA, date: October 24, 2014 - [FDA Inspection 901775 - Fresenius Kabi USA, LLC - 2014-10-24](https://www.globalkeysolutions.net/records/fda_inspections/fresenius-kabi-usa-llc/338bfa08-73cf-419a-a687-b12adcba504e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 24, 2014 - [FDA Inspection 901775 - Fresenius Kabi USA, LLC - 2014-10-24](https://www.globalkeysolutions.net/records/fda_inspections/fresenius-kabi-usa-llc/d1d6cd6a-a864-4fe6-9ef7-bcd0769b86d0) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 24, 2014 - [483 - Fresenius Kabi USA, LLC - 2011-07-08](https://www.globalkeysolutions.net/records/483/fresenius-kabi-usa-llc/a396774c-8281-464e-859d-99698920571c) — source: FDA, date: July 8, 2011 ## Related Companies - [Pharmaceutics International, Inc.](https://www.globalkeysolutions.net/companies/pharmaceutics-international-inc/38fdf7bd-a7f3-486e-b74d-13b87414922e) - [Bioreliance Ltd.](https://www.globalkeysolutions.net/companies/bioreliance-ltd/fec1a160-db6a-4ebc-9632-aa6e2996e17e) - [Nang Kuang Pharmaceutical Co., Ltd.](https://www.globalkeysolutions.net/companies/nang-kuang-pharmaceutical-co-ltd/bdb8b0bb-4a8d-4f50-a72d-e250626e2818) - [SpecGx, LLC](https://www.globalkeysolutions.net/companies/specgx-llc/ee069c18-3128-4bbe-9c13-768b4837810f) - [MSN Laboratories Private Limited (Formulations Division, Unit-II)](https://www.globalkeysolutions.net/companies/msn-laboratories-private-limited-formulations-division-unit-ii/44914049-4b84-4bac-abac-9af09a223eb8) - [KOFU FACTORY OF TERUMO CORP.](https://www.globalkeysolutions.net/companies/kofu-factory-of-terumo-corp/e0540434-5dcb-4074-851e-f91bd8bfbbf1) - [Zydus Animal Health and Investments Limited](https://www.globalkeysolutions.net/companies/zydus-animal-health-and-investments-limited/6ee7ae45-9697-481a-9899-ca397a4ed653) - [Nucrogene Inc](https://www.globalkeysolutions.net/companies/nucrogene-inc/501df133-f224-4158-9017-370447fc29a5) - [Alnylam Pharmaceuticals Inc.](https://www.globalkeysolutions.net/companies/alnylam-pharmaceuticals-inc/285be436-d642-438b-ac4c-530088c678b8) - [Oxford Biomedica (UK) Limited](https://www.globalkeysolutions.net/companies/oxford-biomedica-uk-limited/12d29c20-d7d1-4ab9-830f-5d9f25a506ad) ## Related Officers - [Matthew D. Schnittker](https://www.globalkeysolutions.net/people/matthew-d-schnittker/cf76f07f-db6d-47a0-8412-7eb084d4fe8b) - [Charanjeet Jassal](https://www.globalkeysolutions.net/people/charanjeet-jassal/85aad819-fe9c-41dd-8280-23bcbeb8826c) - [Patric C. Klotzbuecher](https://www.globalkeysolutions.net/people/patric-c-klotzbuecher/cbb2e6b5-b001-457e-9073-33535f02926e) - [issuing_officer](https://www.globalkeysolutions.net/people/erika-englund/13d235ca-da4b-40e3-add0-c62372c8c25e) - [Mandy Chan](https://www.globalkeysolutions.net/people/mandy-chan/437eb591-92d9-49ac-943c-33c7584c0b89)